Cerebral blood flow (grey matter flow) in parkinsonism requires further investigation. The nonin vasive method of 133Xe inhalation permits study of larger numbers of subjects than previously used invasive tech niques such as the intracarotid 133Xe injection method.
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compared to the flow values found in other hemispheric regions. In order to achieve this selectivity, we arbitrarily chose F, (grey flow) values obtained from the four most frontal detectors, which correspond most closely to pre frontal regions (Fig. 1) . Placement of the detectors too far to the front was avoided to ensure the most favorable conditions for observation. Determinations of prefrontal cerebral blood flow were made and compared to the mean hemispheric flow recorded by the other detectors.
Regional cerebral blood flow was measured in a total of 55 subjects. Mean arterial pressure (MAP) was monitored continuously by external means, and the Pac02 was esti mated from the end-tidal CO2 content in the expired air.
The subjects were divided into three groups: Group 1 (n = 10), young subjects, free of any organic or functional pa thology (mean age, 26.6 ± 3.3 years); Group 2 (n = 15), aged patients, in good mental health and free of any cere brovascular disease (mean age, 68.2 ± 8.9 years); and Group 3 (n = 30), patients with idiopathic Parkinson's disease (mean age 64.4 ± 7.3 years). Full details about the subjects in Group 3 are given in Table 1 .
Prior to the main investigations, two measurements of CBF were made (in all subjects of Group 1) in order to prove the reproducibility of the technique. During all de terminations of rCBF, the subjects had their eyes closed, the laboratory was kept as silent as possible, and the subjects were neither spoken to nor touched.
RESULTS
In resting wakefulness, with the eyes closed and in the absence of all sensory stimulation, the mean grey matter flow for the subjects of Group 1 was found to be 78. 8 ± 6. 7 mVI00 glmin for the first flow determination. A flow value of the order of + 12.4 ± 2. 9% higher was found in the prefrontal regions, compared to the temporoparietal-occipital regions. At the second determination (2 h after the first), the same subjects showed a flow of 73.9 ± 7.1 mVlOO g/min. Once again, flow in the prefrontal region was approximately 11. 9 ± 5. 4% greater than that in other areas of the cortex (Table 2) . A similar observation was made with the subjects of Group 2. In those 15 subjects, the mean grey matter flow value for the whole of the hemisphere was 76. 3 ± 15. 6 mlilOO glmin. The prefrontal flow in this instance was +8.5 ± 3. 7% higher, compared to the rest of the hemisphere (Table 3) .
Finally, in subjects with Parkinson's disease (Group 3), the mean grey matter flow was found to be 70.4 ± 9. 3 mVlOO glmin with flow in the prefron tal regions being only 1.8 ± 6. 4% greater, compared to values for the temporoparietal-occipital regions (Table 3 ). An illustration of the differences for the flow val ues obtained in the prefrontal regions and expressed as percentage of remaining hemispheric flow is shown in Fig. 2 .
DISCUSSION
In the present investigation, hyperfrontal dis tributions of F 1 values for CBF were measured in young adults of the control group, i.e., the CBF measured by the detectors in the most frontal posi tions was 12.3% greater than the blood flow in the rest of the hemisphere.
This notion of increased CBF in the prefrontal region in resting wakefulness has already been re ported by several authors. Blauenstein et al. (1977) have shown a similar preferential frontal distribu tion of more than 12% when compared to the rest of the hemisphere. It is noteworthy that they obtained the same values for prefrontal CBF when a second measurement was made 24 h after the first. In that study, only seven detectors per hemisphere were used to measure flow following inhalation of 133Xe. Likewise, with the intracarotid bolus technique, Larsen et al. (1978) indicated the presence of a hyperfrontal distribution particularly in the superior part of the prefrontal lobe, which they estimated as having a flow 12% greater than that in the rest of the hemisphere studied. Yet another author, Ingvar (1979) , has particu larly emphasized this notion of hyperfrontality. By intracarotid injection, he estimated it to be between +20 and +40%. In an earlier study, Ingvar and co workers (1976) stressed the correlation existing between the EEG frequency and cerebral blood flow. They suggested that the existence of high fre quencies in prefrontal regions was linked to the local increase of blood flow. These two phenomena suggest a hyperactivity, in the resting condition, of the prefrontal regions that are probably involved in programmatic activity.
The present study has dealt particularly with the loss of hyperfrontality of CBF in the Parkinson's patients. For the 15 age-matched normal subjects whose mean age was 68.2 ± 8.9 years, the flow in the frontal CBF regions was 8.5% greater than the mean for the rest of the hemisphere. The difference is clear when the values are compared to those noted in the Parkinson's patients (p � 0.05); this latter group presents two interesting hemodynamic considerations.
First, there was an overall decrease in mean hemispheric CBF. It reached 70.4 mlJ100 g/min i.e., a decrease of 10.6%, compared with the young adults (p � 0.01), and a decrease of 6.7%, when contrasted to the subjects of the same age group (p < 0.05). These results are in agreement with those recorded by Lavy et al. (1979) , who found mean hemispheric CBF to be 9.5% less than that of the control group. However, Lenzi et al. (1977) , using positron emission tomography, did not indicate any abnormalities in frontal circulation in Parkinson's patients, but did note a decrease of circulatory and metabolic activity in the parietal cortex. The second important observation in the Parkin son's patients, and the one which seems the most interesting to us, was the significant attenuation, indeed the disappearance, of the frontal pattern noted in the young subjects and to a lesser degree in the subjects of comparable age. The prefrontal re gion was no longer preferentially irrigated, the flow there being only + 1.8% greater than that in the rest of the hemisphere. Figure 2 illustrates that for some of the subjects there were no differences, and in some cases even lower blood flow values were found in the frontal regions.
It is tempting to correlate this hemodynamic situ ation with a certain number of clinical or radiologi cal signs that indicate prefrontal lobe damage in Parkinson's patients. A part of the clinical semiol ogy may be considered as prefrontal. In addition, on the radiological level, computerized tomography makes it possible to point out a cortical atrophy J Cereb Blood FI",\, Mc{abol, Vol, 3, No, 1, 1983 particularly noticeable in prefrontal regions (Adam et aI., 1982) , Concerning hemodynamics, we feel it is interest ing to relate this prefrontal damage to what is known about the ascending dopaminergic pathways. Lindvall and Bjorklund (1978) showed that a certain number of fasciculi leave the brainstem nuclei (mainly AIO) and head towards both the limbic system and the prefrontal cortex. It is probable, then, that the dopaminergic pathways exert some control on the metabolic and circulatory activity of the cortex. In animals, administration of a dopa minergic agonist considerably stimulates the circu lation (Edvinsson et aI., 1978; McCulloch and Ed vinsson, 1980) ; in the monkey, piribedil or apo morphine increases CBF by 40%. Kelly and McCulloch (1981) demonstrated that apomorphine administration in rats results precisely in a prefer ential increase of the CBF in the prefrontal region of up to 40%. It is also associated with comparable regional glucose utilization increases (30%). Fur thermore, Giiell et al. (1982) showed that, in man, administration of a dopaminergic agonist at a dose of 0.2 mg/kg increases CBF. Possible selective ac tion in the prefrontal region was not studied.
We suggest that the decrease of CBF in the pre frontal region of Parkinson's patients may be re lated to the degeneration of ascending dopaminergic pathways. It is now well known that degeneration of the dopaminergic pathways is not limited to the ni grostriatal pathway, but that the whole dopaminergic system is involved. A moderate degree of disparity appears in our first results, and it is logical to think that all Parkinson's subjects do not present the same degree of damage to the ascending dopamin ergic pathways. The majority of our patients do show a prefrontal semiology, the hemodynamic consequences of which we have described above. Other patients, on the contrary, are relatively un affected; some show no hemodynamic modification in this area, maintaining essentially normal hyper frontality.
A study in progress will perhaps make it possible to establish a relationship between the hemody namics and the clinical semiology. Therefore, it will be interesting to see if the use of a dopaminergic agonist, acting on the second neuron, can stimulate the prefrontal region and reestablish normal cir culatory and metabolic activity. Research is pres ently under way with the dopaminergic agonists piribedil, bromocriptine, and apomorphine.
